Purchase Order HHSN268201400152P

<p>The National Heart Lung and Blood Institute issued a $38,844 delivery order to Illumina, Inc. on November 4, 2014, for genetic sequencing and genomic analysis equipment and materials, with an ultimate completion date of August 31, 2015.</p> <p>Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The source does not identify the parent vehicle under which this delivery order was issued.</p>

<p>The National Heart Lung and Blood Institute issued a $61,208.46 delivery order to Illumina, Inc. on September 14, 2015, for genetic sequencing and genomic analysis equipment and reagents.</p> <p>Place of performance is Bethesda, MD. The order carried a firm fixed-price structure with an ultimate completion date of September 2, 2020. No set-aside was used.</p>

<p>The National Heart Lung and Blood Institute issued a $84,341 delivery order to Illumina, Inc. on July 6, 2015, for genetic sequencing and genomic analysis technologies on a firm fixed-price basis.</p> <p>Place of performance is Bethesda, MD. The order ceiling value is $84,341 with an ultimate completion date of August 31, 2015. No set-aside was used in this award.</p>

<p>The National Heart Lung and Blood Institute issued an $86,587 delivery order to Illumina, Inc. on February 2, 2015, for genetic sequencing reagents and related genomic analysis materials.</p> <p>Place of performance is Bethesda, MD. The order carries a firm fixed-price structure with an ultimate completion date of August 31, 2015. No set-aside was applied.</p>

<p>The National Heart Lung and Blood Institute issued a $5,243 delivery order to Illumina, Inc. on July 8, 2015, for genetic sequencing reagents and consumables, with ultimate completion on July 17, 2015.</p> <p>Place of performance is Bethesda, MD. The order is firm fixed price with no set-aside.</p>

<p>The National Heart Lung and Blood Institute issued a $33,291 delivery order to Illumina, Inc. on September 4, 2014, for genetic sequencing reagents and consumables supporting genomic research.</p> <p>Place of performance is Bethesda, Maryland. The order carries a firm fixed-price structure with an ultimate completion date of August 31, 2015. No set-aside was applied.</p>

<p>The National Heart Lung and Blood Institute issued a $108,771 delivery order to Illumina, Inc. on December 19, 2014, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order is firm fixed price with an ultimate completion date of August 31, 2015. The source does not identify the parent IDIQ or GWAC vehicle under which this delivery order was issued.</p>

<p>The National Heart Lung and Blood Institute issued a $12,181 delivery order to Illumina, Inc. on September 19, 2014, for firm fixed-price procurement of genetic sequencing equipment and reagents.</p> <p>Place of performance is Bethesda, MD. The order has an ultimate completion date of August 31, 2015. No set-aside was used.</p>

<p>The National Heart Lung and Blood Institute issued a $23,099 delivery order to Illumina, Inc. on November 18, 2014, for genetic sequencing equipment and related supplies, with performance at Bethesda, MD and completion by August 31, 2015.</p> <p>The order is firm fixed price with no set-aside designation.</p>

<p>The National Heart Lung and Blood Institute issued a $21,903 delivery order to Illumina, Inc. on October 27, 2014, for genetic sequencing reagents and consumables. Place of performance is Bethesda, MD. The order has a firm fixed price and an ultimate completion date of August 31, 2015. No set-aside was used for this delivery order.</p>